Join to view full profile
620 S Taylor Ave# DvSt. Louis, MO 63110
Phone+1 314-362-9098
Fax+1 314-362-9851
Dr. Budge is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Vanderbilt University Medical CenterFellowship, Infectious Disease, 2011 - 2014- Vanderbilt University Medical CenterResidency, Internal Medicine, 2007 - 2009
Vanderbilt University School of MedicineClass of 2007
Certifications & Licensure
MO State Medical License 2014 - 2027
TN State Medical License 2009 - 2015
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Infectious Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR, Allscripts, 2015-2017
- CMS Meaningful Use Stage 2 Certification Allscripts TouchWorks EHR, Allscripts, 2015-2017
- CMS Meaningful Use Stage 1 Certification Allscripts TouchWorks EHR, Allscripts, 2015-2017
Clinical Trials
- Spontaneous Antigenemia in Loiasis Start of enrollment: 2020 Jan 23
Publications & Presentations
PubMed
- The Death to Onchocerciasis and Lymphatic Filariasis (DOLF) project: Accomplishments and ongoing research.Peter U Fischer, Christopher L King, Philip J Budge, Gary J Weil,
Plos Neglected Tropical Diseases. 2026-02-01 - Moxidectin combination therapies for lymphatic filariasis-36-month follow-up.Philip J Budge, Catherine M Bjerum, Allassane Foungoye Ouattara, Peter U Fischer, Guibehi Benjamin Koudou
The Lancet. Infectious Diseases. 2025-12-01 - 2 citationsMoxidectin combination therapies for lymphatic filariasis: an open-label, observer-masked, randomised controlled trial.Guibehi Benjamin Koudou, Catherine M Bjerum, Foungoye Allassane Ouattara, Toki Pascal Gabo, Charles W Goss
The Lancet. Infectious Diseases. 2025-10-01
Press Mentions
HMN 2025: How Moxidectin May Present a Quicker Path to Eliminating Parasitic an Infection Endemic to AfricaMay 8th, 2025- Accelerating the Fight Against Parasitic Infections Endemic to AfricaMay 7th, 2025
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
